Hélène Vellemans
Onco-hematology
Dr. Hélène Vellemans MD
CHU UCL Namur, Site Godinne, Department of Hematology
Expertise and research interests
Clinical Hematology
Chronic Lymphocytic Leukemia
Research project(s)
Selected publications
Sansen PY, Montfort L, Nanquette A, Depaus J, Vellemans H. Complete Remission in a TEMPI Syndrome Treated with a Daratumumab, Lenalidomide, and Dexamethasone-Based Regimen: A Case Report. Case Rep Oncol. 2024 Jan 31;17(1):175-179.
Vellemans H, André MPE. Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma. Cancers (Basel). 2021 Jul 26;13(15):3745.
Vellemans H, André M, Delrée P, Devalet B, Depaus J, Collinge E, Sonet A. Cerebral Toxoplasmosis in a Patient with Chronic Lymphocytic Leukemia Treated With Obinutuzumab-Chlorambucil. Am J Biomed Sci & Res. 2021 - 14(2). AJBSR.MS.ID.001968.